Bisphosphonates to prevent skeletal morbidity in patients with lung cancer with bone metastases.
Price
Nancy
N
D001859:Bone Neoplasms / Q000150:complications* / Q000517:prevention & control / Q000556:secondary*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications* / Q000517:prevention & control / Q000556:secondary*; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000517:prevention & control / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D011379:Prognosis; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid